Efficiency of afala in complex therapy of patients with chronic prostatitis.
The use of afala in complex treatment of patients with chronic prostatitis improves the efficiency of therapy and prolongs its positive results. The preparation is well tolerated, has no contraindication, and can be combined with other drugs. Afala is indicated for patients with stages II and IIIa chronic prostatitis from the first day of therapy.
Kul'chavenya
E V
EV
Medical Center Biover, Novosibirsk.
D000328:Adult; D000906:Antibodies / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy / Q000473:pathology; D011472:Prostatitis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
D000906:Antibodies; D007155:Immunologic Factors; C533336:afala